Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
Details
The purpose of this research is to explore the association between personality and adherence to oral cancer medication in patients with chronic myeloid leukemia (CML).
Eligibility
You can join if...
Please note this may not be a complete list of eligibility criteria. We have included a few examples of study criteria to help you better understand how your eligibility in the study will be determined; your study team will go through the study eligibility criteria with you to verify if you qualify for participation in this study.
Inclusion Requirements
You can participate in this study if you are:
• 18 years of age or older
• Diagnosed with chronic myeloid leukemia (CML) and in the chronic phase (CML-CP)
• Currently being treated with one of six cancer medications – imatinib, dasatinib, bosutinib, asciminib, ponatinib, or nilotinib
• A patient at the UCI Chao Family Comprehensive Cancer Center (CFCCC), or
• A member of a patient support group organized by the CML Buster Foundation
• Do not meet any of the criteria listed under “Exclusion Requirements”
Exclusion Requirements
You cannot participate in this study if
• Unable to read and speak English and Spanish
• Impaired decisional capacity to consent